CD8A and in situ carcinoma: However, pT1 bladder cancers confirmed the highest count (mean ± SD) of CD3+ T cells (983.7 ± 662.0; p = 0.022), CD8+ T cells (359.9 ± 238.0; p = 0.008) and CD68+ TAMs (181.6 ± 93.9; p = 0.014) compared to pTa bladder cancer and CIS.